Starpharma Propriété institutionnelle
Quel est le Propriété institutionnelle de Starpharma?
Le Propriété institutionnelle de Starpharma Holdings Limited est 42.81%
Quelle est la définition de Propriété institutionnelle?
La propriété institutionnelle est le montant des actions disponibles d'une société détenues par des fonds mutuels ou des fonds de pension, des compagnies d'assurance, des sociétés d'investissement, des fonds de dotation ou d'autres grandes entités qui gèrent des fonds pour le compte de tiers.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Propriété institutionnelle des entreprises dans Health Care secteur sur ASX par rapport à Starpharma
Que fait Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Entreprises avec propriété institutionnelle similaire à Starpharma
- T-Mobile US a Propriété institutionnelle de 42.78%
- Rubis SCA a Propriété institutionnelle de 42.78%
- Orora a Propriété institutionnelle de 42.79%
- Sculptor Capital Management a Propriété institutionnelle de 42.79%
- Sculptor Capital Management a Propriété institutionnelle de 42.79%
- The Great Eastern Shipping a Propriété institutionnelle de 42.80%
- Starpharma a Propriété institutionnelle de 42.81%
- Dish TV India a Propriété institutionnelle de 42.82%
- Middlefield Canadian Income PCC a Propriété institutionnelle de 42.83%
- Fuelcell Inc a Propriété institutionnelle de 42.84%
- Grupo Televisa SAB a Propriété institutionnelle de 42.84%
- UniCredit SpA a Propriété institutionnelle de 42.85%
- W & T Offshore Inc a Propriété institutionnelle de 42.85%